Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study

A. Ayhan, I. Çiçin, A. Gökyer, M. Sarı, A. Turan, S. Taşkın, K. Gungorduk, O. Akbayir, P. Saip, H. Şahin, G. Çoban, S. Topuz, I. Selcuk, G. Tulunay, M. Meydanlı
{"title":"Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study","authors":"A. Ayhan, I. Çiçin, A. Gökyer, M. Sarı, A. Turan, S. Taşkın, K. Gungorduk, O. Akbayir, P. Saip, H. Şahin, G. Çoban, S. Topuz, I. Selcuk, G. Tulunay, M. Meydanlı","doi":"10.37047/jos.2019-73073","DOIUrl":null,"url":null,"abstract":"78 Ovarian carcinosarcoma (OCS), accounting for only 1-4% of all ovarian malignancies, is a rare neoplasm characterized by sarcomatous and epithelial elements.1-3 Some authors have proposed that OCSs originate from the müllerian epithelium and then differentiation/metaplasia to a sarcomatous structure, supporting the hypothesis that OCS is a metaplastic epithelial carcinoma.4-6 OCS is highly aggressive and has a poor prognosis, presenting with a disease that has spread beyond the ovary in up to 90% of cases at Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"78-86"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37047/jos.2019-73073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

78 Ovarian carcinosarcoma (OCS), accounting for only 1-4% of all ovarian malignancies, is a rare neoplasm characterized by sarcomatous and epithelial elements.1-3 Some authors have proposed that OCSs originate from the müllerian epithelium and then differentiation/metaplasia to a sarcomatous structure, supporting the hypothesis that OCS is a metaplastic epithelial carcinoma.4-6 OCS is highly aggressive and has a poor prognosis, presenting with a disease that has spread beyond the ovary in up to 90% of cases at Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
最佳细胞减少是卵巢癌肉瘤的独立预后因素:土耳其妇科肿瘤组研究
卵巢癌肉瘤(OCS)是一种罕见的肿瘤,以肉瘤和上皮成分为特征,仅占所有卵巢恶性肿瘤的1-4%。1-3一些作者提出OCS起源于勒氏上皮,然后分化/化生为肉瘤结构,支持OCS是一种化生上皮癌的假设。4-6 OCS具有高度侵袭性,预后差,在高达90%的病例中表现为疾病已扩散到卵巢以外:最佳细胞减少是卵巢癌肉瘤的独立预后因素:一项土耳其妇科肿瘤小组研究
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
16
审稿时长
29 weeks
期刊最新文献
A Novel Tumor Marker for Anaplastic Lymphoma Kinase (+) Lymphoma: Beta-Human Chorionic Gonadotropin Initial Albumin-Bilirubin Grade as a Prognostic Indicator of Pancreatic Cancer with Liver Metastasis Investigation of a Glioblastoma Risk-Associated SNP of the PTPRB Gene in Familial Glioblastoma Lung Carcinoma Developing Afatinib-Associated Skin Reactions Immunotherapy for Lung Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1